YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Yubo International Biotech Ltd
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $886.19K
- P/E (TTM)
- –
- Dividend yield
- –
Yubo International Biotech statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Income (trailing twelve months)
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Revenue | $12.35K | $102.39M |
| Gross Profit | $8.17K | $60.36M |
| Operating Income | -$1.12M | -$4.31M |
| Pretax Income | -$1.16M | -$2.37M |
| Net Income | -$1.01M | -$6.57M |
| EBITDA | -$1.01M | -$1.98M |
| EPS (Diluted) | $0.00 | -$0.08 |
Margins
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Gross Margin | 66.1% | 55.2% |
| Operating Margin | -9096.9% | -6.04% |
| Pretax Margin | -9386.8% | -4.11% |
| Profit Margin | -8157.3% | -10.5% |
| EBITDA Margin | -8197.4% | -2.67% |
Returns
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Return on Assets (ROA) | -116.9% | -13.3% |
Growth
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -50.9% | 7.08% |
Balance sheet
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.99K | $36.66M |
| Net Cash (Debt) | $11.99K | $3.92M |
| Net Cash Per Share | $0.00 | $0.28 |
| Equity (Book Value) | -$2.62M | $55.33M |
| Book Value Per Share | -$0.02 | $2.87 |
| Tangible Book Value | -$2.66M | $10.79M |
| Working Capital | -$2.74M | $56.72M |
Financial position
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Current Ratio | 0.18 | 2.48 |
| Quick Ratio | 0.05 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Operating Cash Flow | -$727.99K | -$566.22K |
Efficiency
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.58 |
| Inventory Turnover | 0.13 | 2.21 |
Shares
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Shares Outstanding | 170,421,000 | 44,302,700 |
| Shares Change (YoY) | 37.6% | 3.36% |
| Float | 42,737,900 | 37,462,700 |
| Shares Held by Insiders | 74.9% | 10.5% |
Taxes
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Income Tax | $0 | $1.52M |
Scores
| Measure | Yubo International Biotech | Industry median |
|---|---|---|
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Yubo International Biotech's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.